FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093489637> ?p ?o ?g. }

• W2093489637 endingPage "37877" @default.
• W2093489637 startingPage "37870" @default.
• W2093489637 abstract "The signaling pathway that triggers morphological differentiation of PC12 cells is mediated by extracellular signal-regulated kinase (ERK), the classic mitogen-activated protein (MAP) kinase. However, mediators of the pathway downstream of ERK have not been identified. We show here that phospholipase D2 (PLD2), which generates the pleiotropic signaling lipid phosphatidic acid (PA), links ERK activation to neurite outgrowth in nerve growth factor (NGF)-stimulated PC12 cells. Increased expression of wild type PLD2 (WT-PLD2) dramatically elongated neurites induced by NGF stimulation or transient expression of the active form of MAP kinase-ERK kinase (MEK-CA). The response was activity-dependent, because it was inhibited by pharmacological suppression of the PLD-mediated PA production and by expression of a lipase-deficient PLD2 mutant. Furthermore, PLD2 was activated by MEK-CA, whereas NGF-stimulated PLD2 activation and hypertrophic neurite extension were blocked by an MEK-specific inhibitor. Taken together, these results provide evidence that PLD2 functions as a downstream signaling effector of ERK in the NGF signaling pathway, which leads to neurite outgrowth by PC12 cells. The signaling pathway that triggers morphological differentiation of PC12 cells is mediated by extracellular signal-regulated kinase (ERK), the classic mitogen-activated protein (MAP) kinase. However, mediators of the pathway downstream of ERK have not been identified. We show here that phospholipase D2 (PLD2), which generates the pleiotropic signaling lipid phosphatidic acid (PA), links ERK activation to neurite outgrowth in nerve growth factor (NGF)-stimulated PC12 cells. Increased expression of wild type PLD2 (WT-PLD2) dramatically elongated neurites induced by NGF stimulation or transient expression of the active form of MAP kinase-ERK kinase (MEK-CA). The response was activity-dependent, because it was inhibited by pharmacological suppression of the PLD-mediated PA production and by expression of a lipase-deficient PLD2 mutant. Furthermore, PLD2 was activated by MEK-CA, whereas NGF-stimulated PLD2 activation and hypertrophic neurite extension were blocked by an MEK-specific inhibitor. Taken together, these results provide evidence that PLD2 functions as a downstream signaling effector of ERK in the NGF signaling pathway, which leads to neurite outgrowth by PC12 cells. Axonal outgrowth and guidance are critical events in the establishment of neuronal networks during brain development and are regulated by extracellular guidance cues such as chemoattractants and chemorepellents (1Keynes R.J. Cook G.M. Curr. Opin. Neurobiol. 1995; 5: 75-82Crossref PubMed Scopus (87) Google Scholar, 2Tessier-Lavigne M. Goodman C.S. Science. 1996; 274: 1123-1133Crossref PubMed Scopus (2703) Google Scholar). The attractant and repellent signals are sensed by growth cones at the tips of axons and cause the axons to undergo extension in a directional manner. Several lines of evidence suggest that members of Rho family GTPases, Rho, Rac, and Cdc42, direct the axonal extension by reorganizing the growth cone actin cytoskeleton (3Narumiya S. Ishizaki T. Watanabe N. FEBS Lett. 1997; 410: 68-72Crossref PubMed Scopus (330) Google Scholar, 4Hall A. Science. 1998; 279: 509-514Crossref PubMed Scopus (5227) Google Scholar, 5Luo L. Jan L.Y. Jan Y.N. Curr. Opin. Neurobiol. 1997; 7: 81-86Crossref PubMed Scopus (172) Google Scholar, 6Kaibuchi K. Kuroda S. Amano M. Annu. Rev. Biochem. 1999; 68: 459-486Crossref PubMed Scopus (891) Google Scholar). RhoA regulates the repulsive signaling pathway through its target molecule Rho-associated kinase, termed ROCK (7Wahl S. Barth H. Ciossek T. Aktories K. Mueller B.K. J. Cell Biol. 2000; 149: 263-270Crossref PubMed Scopus (338) Google Scholar, 8Hirose M. Ishizaki T. Watanabe N. Uehata M. Kranenburg O. Moolenaar W.H. Matsumura F. Maekawa M. Bito H. Narumiya S. J. Cell Biol. 1998; 141: 1625-1636Crossref PubMed Scopus (412) Google Scholar, 9Amano M. Chihara K. Nakamura N. Fukata Y. Yano T. Shibata M. Ikebe M. Kaibuchi K. Genes Cells. 1998; 3: 177-188Crossref PubMed Scopus (220) Google Scholar), which in turn regulates myosin II and LIM kinase (8Hirose M. Ishizaki T. Watanabe N. Uehata M. Kranenburg O. Moolenaar W.H. Matsumura F. Maekawa M. Bito H. Narumiya S. J. Cell Biol. 1998; 141: 1625-1636Crossref PubMed Scopus (412) Google Scholar, 9Amano M. Chihara K. Nakamura N. Fukata Y. Yano T. Shibata M. Ikebe M. Kaibuchi K. Genes Cells. 1998; 3: 177-188Crossref PubMed Scopus (220) Google Scholar). We and others have also recently reported that phosphatidylinositol 4-phosphate 5-kinase (PI4P 5-kinase), 1The abbreviations used are: PI4P 5-kinase, phosphatidylinositol 4-phosphate 5-kinase; PLD, phospholipase D; PA, phosphatidic acid; PEt, phosphatidylethanol; PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate; ERK, extracellular signal-regulated kinase; MAP, mitogen-activated protein; MEK, MAP kinase-ERK kinase; GFP, green fluorescent protein; NGF, nerve growth factor; PBS, phosphate-buffered saline; BSA, bovine serum albumin; WT, wild type; LD, lipase-deficient; MEKCA, active form of MEK; HA, hemagglutinin; HRP, horseradish peroxidase. which phosphorylates phosphatidylinositol 4-phosphate at the D-5 position of the inositol ring to produce the versatile lipid signaling molecule phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), functions as a downstream effector of Rho/ROCK in lysophosphatidic acid-induced neurite retraction for mouse neuroblastoma N1E-115 cells (10Yamazaki M. Miyazaki H. Watanabe H. Sasaki T. Maehama T. Frohman M.A. Kanaho Y. J. Biol. Chem. 2002; 277: 17226-17230Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar, 11van Horck F.P. Lavazais E. Eickholt B.J. Moolenaar W.H. Divecha N. Curr. Biol. 2002; 12: 241-245Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). On the other hand, Rac has been implicated in axonal outgrowth (12Kozma R. Sarner S. Ahmed S. Lim L. Mol. Cell. Biol. 1997; 17: 1201-1211Crossref PubMed Scopus (535) Google Scholar) via controlling the neuron-specific, cyclin-dependent kinase 5 regulator, p35 (13Nikolic M. Chou M.M. Lu W. Mayer B.J. Tsai L.H. Nature. 1998; 395: 194-198Crossref PubMed Scopus (352) Google Scholar, 14Rashid T. Banerjee M. Nikolic M. J. Biol. Chem. 2001; 276: 49043-49052Abstract Full Text Full Text PDF PubMed Scopus (127) Google Scholar). Another signaling pathway intermediate well known to be involved in regulating neurite outgrowth is the classic mitogen-activated protein (MAP) kinase, extracellular signal-regulated kinase (ERK). Neurite outgrowth from neurons and neuronal cell lines induced by stimulation of neural cell adhesion molecules, such as L1, or by neurotrophines, such as nerve growth factor (NGF), absolutely requires the activation of ERK (15Doherty P. Williams G. Williams E.J. Mol. Cell. Neurosci. 2000; 16: 283-295Crossref PubMed Scopus (139) Google Scholar, 16Klesse L.J. Meyers K.A. Marshall C.J. Parada L.F. Oncogene. 1999; 18: 2055-2068Crossref PubMed Scopus (184) Google Scholar). The one or more downstream signaling pathways that couple ERK to neurite outgrowth, however, have not yet been clarified. A candidate for signaling downstream of ERK would be the lipid-metabolizing enzyme, phospholipase D2 (PLD2). PLD catalyzes the hydrolysis of the major membrane phospholipid phosphatidylcholine to produce the pleiotropic signaling lipid messenger phosphatidic acid (PA). The mammalian PLD family consists of two related gene products, PLD1 and PLD2 (17Hammond S.M. Jenco J.M. Nakashima S. Cadwallader K. Gu Q. Cook S. Nozawa Y. Prestwich G.D. Frohman M.A. Morris A.J. J. Biol. Chem. 1997; 272: 3860-3868Abstract Full Text Full Text PDF PubMed Scopus (496) Google Scholar, 18Colley W. Sung T. Roll R. Jenco J. Hammond S. Altshuller Y. Bar-Sagi D. Morris A. Frohman M. Curr. Biol. 1997; 7: 191-201Abstract Full Text Full Text PDF PubMed Scopus (638) Google Scholar). PLD1 is directly regulated by classic protein kinase C and members of the ADP-ribosylation factor and Rho family small GTPases in conjunction with polyphosphoinositides, PI(4,5)P2 and phosphatidylinositol 3,4,5-trisphosphate (17Hammond S.M. Jenco J.M. Nakashima S. Cadwallader K. Gu Q. Cook S. Nozawa Y. Prestwich G.D. Frohman M.A. Morris A.J. J. Biol. Chem. 1997; 272: 3860-3868Abstract Full Text Full Text PDF PubMed Scopus (496) Google Scholar). This PLD isozyme appears to play substantial roles in a wide variety of cellular signaling pathways, membrane vesicle trafficking, and exocytosis (19Chen Y.G. Siddhanta A. Austin C.D. Hammond S.M. Sung T.C. Frohman M.A. Morris A.J. Shields D. J. Cell Biol. 1997; 138: 495-504Crossref PubMed Scopus (242) Google Scholar, 20Vitale N. Caumont A.S. Chasserot-Golaz S. Du G. Wu S. Sciorra V.A. Morris A.J. Frohman M.A. Bader M.F. EMBO J. 2001; 20: 2424-2434Crossref PubMed Scopus (203) Google Scholar, 21Humeau Y. Vitale N. Chasserot-Golaz S. Dupont J.L. Du G. Frohman M.A. Bader M.F. Poulain B. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 15300-15305Crossref PubMed Scopus (142) Google Scholar, 22Freyberg Z. Sweeney D. Siddhanta A. Bourgoin S. Frohman M. Shields D. Mol. Biol. Cell. 2001; 12: 943-955Crossref PubMed Scopus (157) Google Scholar). In contrast to PLD1, little is known regarding the physiological functions and regulatory mechanisms of PLD2, which is constitutively active in the presence of polyphosphoinositides and is fundamentally insensitive to PLD1 activators in vitro (18Colley W. Sung T. Roll R. Jenco J. Hammond S. Altshuller Y. Bar-Sagi D. Morris A. Frohman M. Curr. Biol. 1997; 7: 191-201Abstract Full Text Full Text PDF PubMed Scopus (638) Google Scholar). We previously reported that PLD2, but not PLD1, translocates to actin-based membrane ruffles produced by epidermal growth factor stimulation of HeLa cells (23Honda A. Nogami M. Yokozeki T. Yamazaki M. Nakamura H. Watanabe H. Kawamoto K. Nakayama K. Morris A.J. Frohman M.A. Kanaho Y. Cell. 1999; 99: 521-532Abstract Full Text Full Text PDF PubMed Scopus (703) Google Scholar), indicating that PLD2, possibly through its product PA, is involved in membrane dynamics. Actin-based membrane dynamics in the growth cone is also a critical event for neurite outgrowth in response to chemoattractants (24Dickson B.J. Science. 2002; 298: 1959-1964Crossref PubMed Scopus (1173) Google Scholar). Taken together, these findings led us to speculate that PLD2 is involved in the mechanisms of neurite remodeling. This hypothesis is supported by the report that PLD2 mRNA levels increase strikingly in dentate granule cells in the pre-natal hippocampus and the granule cell layer in cerebellum at early post-natal life (25Colley W.C. Altshuller Y.M. Sue-Ling C.K. Copeland N.G. Gilbert D.J. Jenkins N.A. Branch K.D. Tsirka S.E. Bollag R.J. Bollag W.B. Frohman M.A. Biochem. J. 1997; 326: 745-753Crossref PubMed Scopus (115) Google Scholar, 26Saito S. Sakagami H. Kondo H. Brain Res. Dev. Brain Res. 2000; 120: 41-47Crossref PubMed Scopus (36) Google Scholar), in coincidence with the period during which maximal numbers of neurons are differentiating and pathfinding (27Jacobson M. Developmental Neurobiology. 3rd Ed. Plenum Press, New York1991Crossref Google Scholar). Moreover, Parmentier et al. (28Parmentier J.H. Muthalif M.M. Saeed A.E. Malik K.U. J. Biol. Chem. 2001; 276: 15704-15711Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar) have reported that PLD2 activation through norepinephrine stimulation of rabbit vascular smooth muscle cells is dependent upon ERK activation. These reports prompted us to investigate whether PLD2 serves as a signal-transducing enzyme downstream of ERK in neurite outgrowth. Since PC12 cells have been well established as a model system in which ERK plays a crucial role in NGF-induced neurite outgrowth (29Pang L. Sawada T. Decker S.J. Saltiel A.R. J. Biol. Chem. 1995; 270: 13585-13588Abstract Full Text Full Text PDF PubMed Scopus (896) Google Scholar, 30Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Abstract Full Text PDF PubMed Scopus (1854) Google Scholar, 31Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar), we established PC12 cell clones that inducibly express wild type (WT) and lipase-deficient (LD) mutants of PLD1 and PLD2. Here we show that PLD2, but not PLD1, is involved in NGF-stimulated neurite outgrowth from PC12 cells. PLD2 activity is up-regulated by ERK upon stimulation of PC12 cells with NGF, and we show that this is functionally critical. These results provide evidence that PLD2 is a novel signaling molecule in the pathway that mediates signaling from ERK to neurite outgrowth in PC12 cells. Plasmids and Antibodies—cDNAs for WT-PLD1 and -PLD2 and their LD mutants were constructed as described previously (32Sung T.C. Roper R.L. Zhang Y. Rudge S.A. Temel R. Hammond S.M. Morris A.J. Moss B. Engebrecht J. Frohman M.A. EMBO J. 1997; 16: 4519-4530Crossref PubMed Scopus (305) Google Scholar) and subcloned into pTRE vector (Clontech Laboratories, Palo Alto, CA) to establish PC12 cell clones in which these proteins can be inducibly expressed. To transiently express WT-PLD2 in PC12 cells, the cDNA for WT-PLD2 was subcloned into pCGN (pCGN-WT-PLD2) (32Sung T.C. Roper R.L. Zhang Y. Rudge S.A. Temel R. Hammond S.M. Morris A.J. Moss B. Engebrecht J. Frohman M.A. EMBO J. 1997; 16: 4519-4530Crossref PubMed Scopus (305) Google Scholar). The expression plasmid for a constitutively active form of MAP kinase-ERK kinase (MEK-CA), pSRα-HA-MEK-CA, was a generous gift of Dr. E. Nishida (Kyoto University, Japan). The expression plasmid for an green fluorescent protein (GFP), pEGFP-N3, was purchased from Clontech Laboratories. A rabbit polyclonal anti-PLD D4 antibody that recognizes both PLD1 and PLD2 was raised against the bacterial recombinant peptide corresponding to amino acids 714-1074 of PLD1 and then affinity-purified. A rat monoclonal anti-mouse PLD2 411A antibody that specifically recognizes mouse PLD2 was generated by a rat medial iliac lymph node method (33Kishiro Y. Kagawa M. Naito I. Sado Y. Cell Struct. Funct. 1995; 20: 151-156Crossref PubMed Scopus (170) Google Scholar). In brief, WKY/NCrj rats were immunized with 0.2 mg of a bacterial recombinant peptide corresponding to amino acids 1-533 of mouse PLD2. After 3 weeks, the lymph node-derived lymphocytes were fused with SP2/O myeromas. The hybridoma clones that produce the anti-mouse PLD2 antibody were selected by enzyme-linked immunosorbent assay and Western blotting. The following antibodies and probes were purchased from commercial sources: anti-ERK2 D-2 and -phosphorylated ERK E-4 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA); rat anti-HA 3F10 antibody (Roche Applied Science, Tokyo, Japan); anti-GFP antibody (MBL, Nagoya, Japan); horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody (Amersham Biosciences, Arlington Heights, IL); HRP-conjugated anti-mouse IgG antibody (BD Transduction Laboratory, Lexington, KY); fluorescein isothiocyanate-conjugated anti-rat IgG antibody (Jackson ImmunoResearch Laboratory, West Grove, PA); and Alexa 488-conjugated anti-rabbit IgG antibody and rhodamine phalloidin (Molecular Probes, Eugene, OR). Establishment of PC12 Clonal Cell Lines and Cell Culture—pTRE plasmids (40 μg each) encoding WT- and LD-PLD isozymes were cotransfected with 2 μg of pTK-Hyg (Clontech) into the PC12 Tet-Off cell line (Clontech) by electroporation. Selection was performed in DMEM containing 10% fetal calf serum, 5% horse serum, 100 μg/ml G418, 200 μg/ml hygromycin B, and 2 μg/ml doxycycline. Colonies were recovered and cultured in medium A consisting of DMEM supplemented with 10% fetal calf serum, 5% horse serum, 100 μg/ml G418, and 100 μg/ml hygromycin B in the presence or absence of 2 μg/ml doxycycline for 3 days. The expression levels of PLDs in the membrane fraction (20 μg of protein) were analyzed by Western blotting. Transfectant clones exhibiting a substantial tetracycline response were selected and maintained in medium A in the presence of 2 μg/ml doxycycline. To assess neurite outgrowth, PC12 clonal cells were cultured on Type I collagen-coated coverslips for 2 days in medium A, followed by further culture for 1 day in medium B consisting of DMEM supplemented with 1% horse serum, 100 μg/ml G418, and 100 μg/ml hygromycin B in the presence or absence of doxycycline, unless otherwise mentioned. In most experiments in which PLD activity was assayed, the PC12 clonal cells were cultured for 3 days in medium A with or without doxycycline on Type I collagen-coated dishes (IWAKI, Chiba, Japan). Transient Expression of MEK-CA and PLD2—In the experiment for inhibition of NGF-induced neurite outgrowth by transiently expressed LD-PLD2, PC12 parental cells were transfected with pEGFP-N3 or pCGN-LD-PLD2 using LipofectAMINE Plus (Invitrogen), followed by 1 day of culture in medium A. To investigate the effects of WT- and LD-PLD2 on MEK-CA-induced neurite outgrowth, MEK-CA was transiently expressed in PC12 clonal cell lines. WT- and LD-PLD2 were inducibly expressed in these PC12 cells by culturing them in the absence of doxycycline for 2 days. Non-induced controls were cultured in the presence of doxycycline. These PC12 clones were transfected with pSRα-HA-MEK-CA using LipofectAMINE Plus. Cells were further incubated for 1 day in the absence or presence of doxycycline and alcohols in medium B, and neurite outgrowth was then assessed. In the MEKCA-dependent PLD2 activation experiments (Fig. 7), parental PC12 cells were transfected with pCGN-WT-PLD2 and/or pSRα-HA-MEK-CA using LipofectAMINE Plus followed by 1 day of culture in medium A. Assay for PLD Activity—PLD activity was assessed by measuring accumulation of the unambiguous PLD activity marker [32P]phosphatidylethanol ([32P]PEt), which is generated in the presence of ethanol. PC12 clonal cells cultured for 3 days in medium A with or without doxycycline, or parental cells transiently expressing WT-PLD2 and/or MEK-CA, were labeled with 25 μCi/ml [32P]Pi at 37 °C for 1.5 h in Pi-free minimal essential medium (Invitrogen) supplemented with 25 mm Hepes, pH 7.5, and 1% bovine serum albumin (BSA). After being washed, the labeled cells were incubated without or with 50 ng/ml NGF (Alomone Laboratories, Jerusalem, Israel) in the presence of 1% ethanol at 37 °C for 30 min. Lipids were extracted by the method of Bligh and Dyer (34Bligh E.G. Dyer W.J. Can. J. Biochem. Physiol. 1959; 37: 911-917Crossref PubMed Scopus (43093) Google Scholar) and separated by thin-layer chromatography using a solvent system of chloroform/methanol/acetic acid (65:35:6 by volume). The [32P]PEt produced was analyzed by a BAS2000 Bio-imaging analyzer (Fuji Photo Film, Tokyo, Japan) and expressed as a percentage of total [32P]phospholipids. The data are represented as the mean ± difference of duplicate determinations representative of at least three independent experiments with similar results. Western Blotting—Western blotting was performed as previously reported with minor modification (35Watanabe H. Yamazaki M. Miyazaki H. Arikawa C. Itoh K. Sasaki T. Maehama T. Frohman M.A. Kanaho Y. J. Neurochem. 2004; 89: 142-151Crossref PubMed Scopus (51) Google Scholar). In brief, proteins separated by SDS-PAGE were transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% BSA in buffer consisting of 50 mm Tris-HCl, pH 8.0, 2 mm CaCl2, 80 mm NaCl, and 0.2% Nonidet P-40, incubated with primary antibodies in blocking solution, and then with HRP-conjugated second antibodies in blocking solution containing 0.2% SDS and 2% Nonidet P-40. Immunoreactive proteins were detected with an ECL immunoblotting detection reagent (Amersham Biosciences). Immunofluorescent Microscopy—After being treated as described in the figure legends, PC12 cells were fixed, permeabilized, and blocked as previously reported (23Honda A. Nogami M. Yokozeki T. Yamazaki M. Nakamura H. Watanabe H. Kawamoto K. Nakayama K. Morris A.J. Frohman M.A. Kanaho Y. Cell. 1999; 99: 521-532Abstract Full Text Full Text PDF PubMed Scopus (703) Google Scholar). In brief, cells were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) on ice for 30 min. After permeabilization in 0.1% Triton X-100 and 0.1% Tween 20, cells were blocked with 1 mg/ml BSA in PBS, incubated with primary antibodies in PBS supplemented with 0.05% Tween 20 and then with fluorescein isothiocyanate-conjugated anti-rat IgG antibody (1:200 dilution) or Alexa 488-conjugated anti-rabbit IgG antibody (1:1000 dilution). F-actin was stained with rhodamine phalloidin (1:1000 dilution). Cells were imaged using an Axiovert S100 Zeiss fluorescence microscope (Zeiss, Gottingen, Germany). Intracellular localization of overexpressed WT-PLD2 in PC12 cells was determined using a confocal scanner unit CSU21 (Yokogawa Electric Co., Tokyo, Japan) added to the fluorescence microscope. Assay of Neurite Outgrowth—One hundred cells in randomly chosen fields on each coverslip were manually scored by several investigators in a blinded manner. Neurite length was described as the distance between the cell periphery and the tip of neurite, and total length of multiple neurites per cell was calculated. Unless otherwise mentioned, results were represented as the mean ± S.E. from three independent experiments, and statistical significance was evaluated using double-tailed Student's t test. Involvement of PLD2 in NGF-induced Neurite Outgrowth of PC12 Cells—To begin examining the potential involvement of PLD in NGF-stimulated neurite outgrowth, we established PC12 clonal cell lines that inducibly express WT- and LD-PLD1 and -PLD2. We obtained two clonal cell lines that inducibly express WT-PLD2 to different levels (Fig. 1A). Upon PLD2 induction, clone 8, which exhibited the higher level of inducible WT-PLD2 expression, flattened and extended a limited number of short neurites despite the absence of NGF stimulation, whereas clone 11, which expressed less WT-PLD2, remained spherical with protrusions slightly longer than those observed in non-induced cells (Fig. 1B). These protrusions did not extend into neurites, even if the culture period was prolonged further (data not shown). NGF stimulation for 1 day in the absence of PLD2 induction similarly resulted in formation of relatively short neurites (Fig. 1C, top row). Upon PLD2 induction, however, NGF stimulation for 1 day elicited formation of extremely elongated neurites (Fig. 1C, bottom row). Neurites continued to extend in length in control cells treated with NGF over a 6-day period (Fig. 1D). At each time point examined, the neurites in PLD2-induced cells were longer than those in control cells. In contrast to the exaggeration of neurite length, neither neurite number per cell nor neurite branching were affected by WTPLD2 induction (data not shown). Basal activity of PLD increased in a WT-PLD2 expression level-dependent fashion and NGF stimulation further increased the activity (Fig. 1E), demonstrating that NGF receptor signaling is coupled to PLD2 activation. These findings suggested that PLD2 enzymatic activation could be involved in NGF-induced neurite outgrowth. The results observed with PLD2 induction could also reflect its functioning as a scaffolding molecule or nonspecific sequestration of signaling components. To investigate whether the enhancement by PLD2 of the NGF-induced neurite outgrowth depends upon its lipase activity, the consequence of inducing an inactive PLD2 allele (LD-PLD2) was examined (Fig. 2). LD-PLD2 was inducibly expressed by 3- to 5-fold over endogenous PLD2 (Fig. 2A). Induction of LD-PLD2 expression slightly but significantly suppressed both basal and NGF-stimulated PLD activation (Fig. 2B). NGF-induced neurite outgrowth was also inhibited by induction of LD-PLD2 (Fig. 2, C and D). Suppression of the NGF-induced neurite outgrowth by LDPLD2 was additionally demonstrated using transient expression to rule out long term effects of low level LD-PLD2 expression on the clonal cell line as a possible explanation (Fig. 2, E and F). Neurite number per cell and neurite branching were not affected by LD-PLD2 expression (data not shown), again suggesting that PLD2 is involved in neurite elongation but not neurite initiation. The observation that the inactive PLD2 allele did not promote exaggerated neurite extension demonstrates that the facilitation of exaggerated NGF-induced neurite outgrowth by wild-type PLD2 requires its lipase activity. The observation that the inactive PLD2 allele significantly suppressed neurite growth in comparison to control cells further suggested that endogenous PLD2 participates in neurite extension. There are two PLD isoforms, PLD1 and PLD2. To evaluate whether stimulation of the NGF-induced neurite outgrowth is specific to PLD2, we examined PC12 cell clonal cell lines that inducibly expressed WT- and LD-PLD1 (Fig. 3A). In contrast to PLD2, inducible expression of WT- and LD-PLD1 was without effect on the NGF-induced neurite outgrowth and on basal and NGF-stimulated PLD activities (Fig. 3, B and C). These results, taken together with the observations described above, led us to conclude that PLD2, but not PLD1, plays a role in the NGF-triggered neurite extension. The potential involvement of endogenous PLD2 was further explored by examining the consequence of pharmacological suppression of PLD-catalyzed PA production on control and induced cells (Fig. 4). Because NGF-induced neurite outgrowth was exaggerated similarly by WT-PLD2 expression in clones 8 and 11 (Fig. 1D), only clone 11 was used in further studies. When the cells were incubated with 1-butanol, which prevents PLD-catalyzed PA production by preferentially inducing PLD-mediated transphosphatidylation (production of phosphatidylbutanol), NGF-induced neurite outgrowth in both control and PLD2-expressing cells was suppressed (Fig. 4A). In contrast, 2-butanol, which cannot be used as a substrate for PLD-catalyzed transphosphatidylation, instead stimulated NGF-stimulated neurite outgrowth (Fig. 4A). Alcohols can have many effects on cells, and we don't have a mechanistic explanation for how 2-butanol promotes neurite extension. Nevertheless, the 1-butanol-specific inhibition of neurite extension provides additional support for the hypothesis that signaling from PLD2 to NGF-induced neurite outgrowth is mediated by its product PA. PLD2 Mediates Signaling from ERK to Neurite Outgrowth—Activation of ERK is essential for NGF-induced neurite outgrowth from PC12 cells (29Pang L. Sawada T. Decker S.J. Saltiel A.R. J. Biol. Chem. 1995; 270: 13585-13588Abstract Full Text Full Text PDF PubMed Scopus (896) Google Scholar, 30Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Abstract Full Text PDF PubMed Scopus (1854) Google Scholar, 31Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar), and ERK has previously been connected to PLD signaling in other contexts. However, the relationship between the ERK MAP kinase cascade and PLD2 activation remains unclear. In Rat-1 fibroblasts overexpressing the human insulin receptor, PLD2 activates the ERK MAP kinase pathway through the translocation of Raf-1 to the plasma membrane upon insulin stimulation (36Rizzo M.A. Shome K. Vasudevan C. Stolz D.B. Sung T. Frohman M.A. Watkins S.C. Romero G. J. Biol. Chem. 1999; 274: 1131-1139Abstract Full Text Full Text PDF PubMed Scopus (268) Google Scholar). In contrast, however, for PC12 cells and rabbit vascular smooth muscle cells stimulated by hydroxyperoxide and norepinephrine, respectively, PLD2 activation has been reported to be mediated by ERK (28Parmentier J.H. Muthalif M.M. Saeed A.E. Malik K.U. J. Biol. Chem. 2001; 276: 15704-15711Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar, 37Banno Y. Wang S. Ito Y. Izumi T. Nakashima S. Shimizu T. Nozawa Y. Neuroreport. 2001; 12: 2271-2275Crossref PubMed Scopus (31) Google Scholar). We therefore set out to investigate whether PLD2 functions upstream or downstream of ERK in the NGF-induced neurite extension signaling pathway in PC12 cells. As shown in Fig. 5, induction of WT- and LD-PLD2 expression did not affect NGF-induced ERK phosphorylation/activation, eliminating the possibility that PLD2 is an upstream signaling molecule for ERK in this setting. To address the possibility that PLD2 functions downstream of the ERK MAP kinase cascade, we employed the MEK-specific inhibitor PD98059. As reported previously (29Pang L. Sawada T. Decker S.J. Saltiel A.R. J. Biol. Chem. 1995; 270: 13585-13588Abstract Full Text Full Text PDF PubMed Scopus (896) Google Scholar, 38Dudley D.T. Pang L. Decker S.J. Bridges A.J. Saltiel A.S. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 7686-7689Crossref PubMed Scopus (2595) Google Scholar), the inhibitor completely suppresses NGF-induced ERK phosphorylation/activation (Fig. 6A). Moreover, the inhibitor blocked NGF-induced neurite outgrowth from control and PLD2-expressing cells (Fig. 6, B and C), and it suppressed NGF-stimulated PLD2 activation (Fig. 6D). The inhibition was not due to a direct effect of the inhibitor on PLD2, because it failed to suppress PLD2 activity as assessed using an in vitro system (data not shown). These results demonstrate that ERK directly or indirectly activates PLD2 and that ERK stimulation of PLD2 is required for neurite outgrowth. Finally, we employed the constitutively active MEK, MEKCA, to confirm the epistatic relationship of ERK and PLD2 using another approach. Transient co-expression of MEK-CA and WT-PLD2 into parental cells resulted in robust PLD2 activation (Fig. 7). Furthermore, neurite outgrowth stimulated by transient expression of MEK-CA was significantly enhanced by induction of WT-PLD2 expression (Fig. 8, A and B). In contrast, LD-PLD2 expression inhibited MEK-CA-induced neurite outgrowth (Fig. 8, A and B), as did suppression of PLD-mediated PA production by 1-butanol (Fig. 8, C and D). The inhibitory effect of 1-butanol was not attributable to direct inhibition of the MAP kinase cascade, because 1-butanol did not affect the phosphorylation of ERK under these conditions (data not shown). These results, taken together, provide unambiguous evidence that PLD2 activity is up-regulated by activation of ERK, which in turn enhances neurite outgrowth from PC12 cells. PLD2 Co-localizes with F-actin in Growth Cones during Neurite Outgrowth—Because actin-based dynamic reorganization of the membrane in growth cones is one of critical events that takes place during chemoattractant-stimulated neurite outgrowth (24Dickson B.J. Science. 2002; 298: 1959-1964Crossref PubMed Scopus (1173) Google Scholar), we examined whether PLD2 and F-actin co-localize in the growth cone. Consistent with the report by Colley et al. (18Colley W. Sung T. Roll R. Jenco J. Hammond S. Altshuller Y. Bar-Sagi D. Morris A. Frohman M. Curr. Biol. 1997; 7: 191-201Abstract Full Text Full Text PDF PubMed Scopus (638) Google Scholar) with non-neuronal cells, inducibly expressed WT-PLD2 localized at the plasma membrane of soma in non-stimulated PC12 cells and co-localized with F-actin (Fig. 9). Interestingly, at 12 h after the initiation of NGF stimulation, PLD2 was found to be enriched at the growth cone where it again co-localized with F-actin (Fig. 9). These results suggest the possibility that the mechanism through which PLD2 signals to neurite outgrowth in PC12 cells involves actin cytoskeletal reorganization in the growth cone. The ERK MAP kinase cascade plays a crucial role in NGF-induced neurite outgrowth from PC12 cells (29Pang L. Sawada T. Decker S.J. Saltiel A.R. J. Biol. Chem. 1995; 270: 13585-13588Abstract Full Text Full Text PDF PubMed Scopus (896) Google Scholar, 30Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Abstract Full Text PDF PubMed Scopus (1854) Google Scholar, 31Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar). However, the downstream sequence of events that links ERK signaling to neurite outgrowth has remained poorly understood. In the present study, we provide unambiguous evidence that PLD2 functions as a downstream signaling molecule for ERK in this pathway, providing insight not only into the connection between ERK and neurite remodeling, but as well into the regulatory mechanisms that control PLD2 activation in physiological settings. We report here that PLD2 activation downstream of ERK is absolutely required for NGF-induced neurite outgrowth. Activation of PLD2 by itself, however, does not appear to suffice to maximally trigger neurite outgrowth. This conclusion is reached from the observations that overexpression of WT-PLD2 in the PC12 cell line clone 8, in which basal PLD activity was increased to a much greater extent than that observed for NGF-stimulated control cells, induced only limited neurite extension in the absence of NGF (Fig. 1, B and E) but then promoted profoundly exaggerated neurite outgrowth in the presence of NGF. Accordingly, it is likely that PLD2 signaling synergizes with other pathway(s) in parallel to fully promote neurite outgrowth from PC12 cells. Recently, Harada et al. (40Harada T. Morooka T. Ogawa S. Nishida E. Nat. Cell Biol. 2001; 3: 453-459Crossref PubMed Scopus (281) Google Scholar) have reported that the neuron-specific cyclin-dependent kinase 5 activator p35 is induced by NGF stimulation of PC12 cells in an ERK-dependent manner and that p35 induction is essential but insufficient to drive NGF-induced neurite outgrowth. This report, taken together with the result shown in Fig. 8 that the MEK-induced neurite outgrowth was dramatically enhanced by co-expression of WT-PLD2, suggest that the pathway may branch downstream from ERK to activate both PLD2 and p35 in parallel. It would be of interest to investigate whether ERK-dependent p35 induction cooperates with PLD2 to induce neurite outgrowth. Alternatively, PLD2 may coordinate with other regulators known to be involved in controlling neurite outgrowth, such as protein kinase Cϵ (41Brodie C. Bogi K. Acs P. Lazarovici P. Petrovics G. Anderson W. Blumberg P.M. Cell Growth & Differ. 1999; 10: 183-191PubMed Google Scholar), PAK1 (42Daniels R.H. Hall P.S. Bokoch G.M. EMBO J. 1998; 17: 754-764Crossref PubMed Scopus (257) Google Scholar), and c-Jun (43Leppa S. Saffrich R. Ansorge W. Bohmann D. EMBO J. 1998; 17: 4404-4413Crossref PubMed Scopus (291) Google Scholar). The mechanisms that control PLD2 activation in vivo are poorly understood in comparison to those that control PLD1 (17Hammond S.M. Jenco J.M. Nakashima S. Cadwallader K. Gu Q. Cook S. Nozawa Y. Prestwich G.D. Frohman M.A. Morris A.J. J. Biol. Chem. 1997; 272: 3860-3868Abstract Full Text Full Text PDF PubMed Scopus (496) Google Scholar, 44McDermott M. Wakelam M.J. Morris A.J. Biochem. Cell Biol. 2004; 82: 225-253Crossref PubMed Scopus (308) Google Scholar). In the present study, we show that PLD2 activity is regulated by ERK in PC12 cells (Fig. 6). This conclusion is in agreement with reports by Parmentier et al. (28Parmentier J.H. Muthalif M.M. Saeed A.E. Malik K.U. J. Biol. Chem. 2001; 276: 15704-15711Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar) and Banno et al. (37Banno Y. Wang S. Ito Y. Izumi T. Nakashima S. Shimizu T. Nozawa Y. Neuroreport. 2001; 12: 2271-2275Crossref PubMed Scopus (31) Google Scholar) on norepinephrine-stimulated vascular smooth muscle cells and hydroxyperoxide-stimulated PC12 cells, respectively. In contrast, Rizzo et al. (36Rizzo M.A. Shome K. Vasudevan C. Stolz D.B. Sung T. Frohman M.A. Watkins S.C. Romero G. J. Biol. Chem. 1999; 274: 1131-1139Abstract Full Text Full Text PDF PubMed Scopus (268) Google Scholar) elegantly demonstrated in insulin-stimulated Rat-1 fibroblasts that PLD2 activates ERK MAP kinase, which is opposite to what we found for our NGF-stimulated PC12 cells (Fig. 5). This paradox suggests that the relationship between PLD2 and ERK MAP kinase signaling may depend upon the cell types and/or agonists under investigation. Is the activation of PLD2 by ERK direct or indirect? Because purified recombinant PLD2 cannot be activated and phosphorylated in vitro by immunologically precipitated ERK2 (which had been overexpressed in HeLa cells and activated by hydroxyperoxide stimulation, data not shown), it is likely that PLD2 activation by ERK is indirect. PLD2 activation may involve other signaling inputs as well, because the inhibition of the NGF-stimulated PLD2 activity by the PD MEK inhibitor was not complete (Fig. 6D). A key question raised by our findings concerns the molecular mechanisms through which PA produced by PLD2 regulates neurite outgrowth. In non-neuronal cells, PA regulates molecule(s) involved in actin cytoskeleton reorganization and membrane trafficking (45Frohman M.A. Morris A.J. Chem. Phys. Lipids. 1999; 98: 127-140Crossref PubMed Scopus (100) Google Scholar, 46Liscovitch M. Czarny M. Fiucci G. Tang X. Biochem. J. 2000; 345: 401-415Crossref PubMed Scopus (461) Google Scholar), both of which are essential events for neurite outgrowth. Reorganization of the actin cytoskeleton plays crucial roles in axonal outgrowth and guidance of primary cultured neurons (24Dickson B.J. Science. 2002; 298: 1959-1964Crossref PubMed Scopus (1173) Google Scholar, 42Daniels R.H. Hall P.S. Bokoch G.M. EMBO J. 1998; 17: 754-764Crossref PubMed Scopus (257) Google Scholar). Furthermore, actin filaments have been shown to accumulate in the growth cones at the tips of neurites during neuronal development (24Dickson B.J. Science. 2002; 298: 1959-1964Crossref PubMed Scopus (1173) Google Scholar, 47Machesky L.M. Insall R.H. J. Cell Biol. 1999; 146: 267-272Crossref PubMed Scopus (214) Google Scholar). These findings lead us to speculate that PA enhances neurite outgrowth through reorganization of the actin cytoskeleton. This idea is supported by the observation that overexpressed WT-PLD2 in PC12 cells became enriched at the growth cone and colocalized there with F-actin (Fig. 9). In addition, overexpression of WT-PLD2 stimulated filopodia formation in the neurites themselves. 2H. Watanabe and Y. Kanaho, unpublished observation. Of several proteins and enzymes that PA directly interacts with and regulates in vitro, including PI4P 5-kinase (48Jenkins G.H. Fisette P.L. Anderson R.A. J. Biol. Chem. 1994; 269: 11547-11554Abstract Full Text PDF PubMed Google Scholar), protein phosphatase 1γ (49Jones J.A. Hannun Y.A. J. Biol. Chem. 2002; 277: 15530-15538Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar), β-COP (50Manifava M. Thuring J.W. Lim Z.Y. Packman L. Holmes A.B. Ktistakis N.T. J. Biol. Chem. 2001; 276: 8987-8994Abstract Full Text Full Text PDF PubMed Scopus (107) Google Scholar), and PDE4D3 (51Grange M. Sette C. Cuomo M. Conti M. Lagarde M. Prigent A.F. Némoz G. J. Biol. Chem. 2000; 275: 33379-33387Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar), PI4P 5-kinase has been well documented to regulate actin cytoskeletal reorganization through its product PI(4,5)P2 (52Sechi A.S. Wehland J. J. Cell Sci. 2000; 113: 3685-3695Crossref PubMed Google Scholar). It is unlikely, however, that PI4P 5-kinase is the key target signaling molecule of PA in the signaling pathway that regulates NGF-induced neurite outgrowth in PC12 cells, because PI(4,5)P2 levels of non-induced control cells and WT-PLD2-induced cells were indistinguishable and did not significantly change with NGF stimulation (data not shown). In addition, we have recently demonstrated that PI4P 5-kinase functions as a downstream effector for Rho/ROCK in lysophosphatidic acid-induced neurite retraction of N1E-115 cells (10Yamazaki M. Miyazaki H. Watanabe H. Sasaki T. Maehama T. Frohman M.A. Kanaho Y. J. Biol. Chem. 2002; 277: 17226-17230Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar, 11van Horck F.P. Lavazais E. Eickholt B.J. Moolenaar W.H. Divecha N. Curr. Biol. 2002; 12: 241-245Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). These data suggest that PA may regulate reorganization of actin cytoskeleton to extend neurites through one or more mechanisms independent of PI4P 5-kinase and of Rho/ROCK. Alternatively, PA may play a role in supplying membrane components to neurites by facilitating membrane trafficking, as has been demonstrated in non-neuronal cells where PA stimulates budding from the Golgi apparatus by recruiting the cytosolic COP protein β-COP (39Ktistakis N.T. Brown H.A. Waters M.G. Sternweis P.C. Roth M.G. J. Cell Biol. 1996; 134: 295-306Crossref PubMed Scopus (329) Google Scholar). The specific molecular mechanisms through which PA signals to neurite outgrowth remain to be defined. We thank Dr. E. Nishida for the generous gift of pSRα-HA-MEK-CA." @default.
• W2093489637 created "2016-06-24" @default.
• W2093489637 creator A5003220636 @default.
• W2093489637 creator A5005802003 @default.
• W2093489637 creator A5037434685 @default.
• W2093489637 creator A5042371488 @default.
• W2093489637 creator A5046132781 @default.
• W2093489637 creator A5055360718 @default.
• W2093489637 creator A5074588035 @default.
• W2093489637 creator A5077982627 @default.
• W2093489637 creator A5087789028 @default.
• W2093489637 date "2004-09-01" @default.
• W2093489637 modified "2023-10-12" @default.
• W2093489637 title "Essential Role for Phospholipase D2 Activation Downstream of ERK MAP Kinase in Nerve Growth Factor-stimulated Neurite Outgrowth from PC12 Cells" @default.
• W2093489637 cites W1486424890 @default.
• W2093489637 cites W1490481380 @default.
• W2093489637 cites W1637051517 @default.
• W2093489637 cites W1971225568 @default.
• W2093489637 cites W1971915141 @default.
• W2093489637 cites W1973624256 @default.
• W2093489637 cites W1974833672 @default.
• W2093489637 cites W1977678370 @default.
• W2093489637 cites W1981672085 @default.
• W2093489637 cites W1988187090 @default.
• W2093489637 cites W1989480480 @default.
• W2093489637 cites W2008346251 @default.
• W2093489637 cites W2016208760 @default.
• W2093489637 cites W2018633041 @default.
• W2093489637 cites W2024523584 @default.
• W2093489637 cites W2026828159 @default.
• W2093489637 cites W2033131480 @default.
• W2093489637 cites W2033712349 @default.
• W2093489637 cites W2034499208 @default.
• W2093489637 cites W2050621406 @default.
• W2093489637 cites W2055914175 @default.
• W2093489637 cites W2057238483 @default.
• W2093489637 cites W2057703191 @default.
• W2093489637 cites W2058381459 @default.
• W2093489637 cites W2064489682 @default.
• W2093489637 cites W2066833882 @default.
• W2093489637 cites W2072416078 @default.
• W2093489637 cites W2078992684 @default.
• W2093489637 cites W2081240939 @default.
• W2093489637 cites W2082776443 @default.
• W2093489637 cites W2093269765 @default.
• W2093489637 cites W2096791952 @default.
• W2093489637 cites W2104119889 @default.
• W2093489637 cites W2104302589 @default.
• W2093489637 cites W2115654943 @default.
• W2093489637 cites W2117111749 @default.
• W2093489637 cites W2124248841 @default.
• W2093489637 cites W2132052155 @default.
• W2093489637 cites W2139658908 @default.
• W2093489637 cites W2139868649 @default.
• W2093489637 cites W2144033216 @default.
• W2093489637 cites W2145828270 @default.
• W2093489637 cites W2150647809 @default.
• W2093489637 cites W2162049443 @default.
• W2093489637 cites W2167390326 @default.
• W2093489637 cites W2170467038 @default.
• W2093489637 cites W2300552860 @default.
• W2093489637 cites W2340804859 @default.
• W2093489637 cites W4211224007 @default.
• W2093489637 doi "https://doi.org/10.1074/jbc.m402610200" @default.
• W2093489637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15226317" @default.
• W2093489637 hasPublicationYear "2004" @default.
• W2093489637 type Work @default.
• W2093489637 sameAs 2093489637 @default.
• W2093489637 citedByCount "40" @default.
• W2093489637 countsByYear W20934896372012 @default.
• W2093489637 countsByYear W20934896372014 @default.
• W2093489637 countsByYear W20934896372015 @default.
• W2093489637 countsByYear W20934896372016 @default.
• W2093489637 countsByYear W20934896372017 @default.
• W2093489637 countsByYear W20934896372018 @default.
• W2093489637 countsByYear W20934896372020 @default.
• W2093489637 countsByYear W20934896372023 @default.
• W2093489637 crossrefType "journal-article" @default.
• W2093489637 hasAuthorship W2093489637A5003220636 @default.
• W2093489637 hasAuthorship W2093489637A5005802003 @default.
• W2093489637 hasAuthorship W2093489637A5037434685 @default.
• W2093489637 hasAuthorship W2093489637A5042371488 @default.
• W2093489637 hasAuthorship W2093489637A5046132781 @default.
• W2093489637 hasAuthorship W2093489637A5055360718 @default.
• W2093489637 hasAuthorship W2093489637A5074588035 @default.
• W2093489637 hasAuthorship W2093489637A5077982627 @default.
• W2093489637 hasAuthorship W2093489637A5087789028 @default.
• W2093489637 hasBestOaLocation W20934896371 @default.
• W2093489637 hasConcept C113246987 @default.
• W2093489637 hasConcept C132149769 @default.
• W2093489637 hasConcept C162324750 @default.
• W2093489637 hasConcept C170493617 @default.
• W2093489637 hasConcept C184235292 @default.
• W2093489637 hasConcept C185592680 @default.
• W2093489637 hasConcept C202751555 @default.
• W2093489637 hasConcept C21547014 @default.
• W2093489637 hasConcept C2776207758 @default.
• W2093489637 hasConcept C2778423431 @default.

• next